Karyopharm Therapeutics, Inc. (KPTI)
8.77
+0.46
(+5.54%)
USD |
NASDAQ |
May 01, 16:00
8.77
0.00 (0.00%)
After-Hours: 18:19
Karyopharm Therapeutics Market Cap : 160.88M for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 163.41B |
| Catalyst Pharmaceuticals, Inc. | 3.509B |
| Alnylam Pharmaceuticals, Inc. | 39.48B |
| Agios Pharmaceuticals, Inc. | 1.676B |
| Ocugen, Inc. | 607.64M |
Market Cap Related Metrics
| PS Ratio | 0.6554 |
| PEG Ratio | -0.0019 |
| Price | 8.77 |
| Earnings Yield | -189.5% |
| PEGY Ratio | -0.0019 |